Kroger Post-Earnings: Short Sellers Retreat as Analysts Lift Targets

KR has cleared its October 20 earnings hurdle, and the most telling move since the print is not in the stock price but in how the positioning picture has shifted.

The pre-earnings build in short interest has begun to unwind. Short interest now runs at 4.51% of the free float, down from a peak above 4.6% earlier in October and roughly 3% lower than a month ago. The lending market was never under pressure to begin with: availability remains exceptionally loose at 1,521%, meaning the pool of shares available to borrow dwarfs the number already lent out. That figure is well above even the 52-week trough of 682%. Cost to borrow has also eased, pulling back around 11% on the week to 0.43%, its lowest level in several weeks. None of this looks like a market betting hard on further downside. The borrow conditions tell a story of a stock that shorts can enter and exit freely, with no squeeze mechanics in play.

Options sentiment has moved notably since the pre-earnings call-heavy positioning flagged in previous notes. The put/call ratio has climbed back to 0.72, above its 20-day mean of 0.69 and at its highest one-day reading in nearly three weeks. That is a rotation away from the aggressive call positioning that characterised the run-up, when the ratio briefly fell to 0.57 in early October. Post-earnings rebalancing is the most straightforward explanation: the event has passed, the vol-selling community is stepping back in, and the skew is normalising. The z-score of 0.68 puts current positioning only fractionally above average, so this is not a bearish signal so much as the absence of an unusually bullish one.

The analyst community is responding to the print with measured upgrades. Two actions landed this morning. Wells Fargo raised its target from $58 to $60 while holding its Equal-Weight rating, a move that keeps the stock in neutral territory for that firm. Guggenheim was more constructive, lifting its target from $66 to $68 and reiterating Buy. Those two moves are directionally consistent with each other but tell different stories about conviction: one firm sees fair value near the current price, the other sees roughly 8% upside from yesterday's close of $62.98. The consensus mean target across the Street is $68.91. Bulls point to Kroger's scale, private-label strength, and pharmacy business as durable earnings drivers, and note that sales came in $209 million above expectations in the most recent print. Bears counter that underlying food volumes fell 1.2%, SG&A is growing faster than sales, and competitive pressure from mass, club, and e-commerce formats leaves little room for error. The EV/EBITDA multiple at 7.2x and PE at 11.6x both sit below historical ranges, which keeps the valuation case intact for patient holders. The EPS momentum factor score, however, ranks only in the 34th percentile over 30 days and the 29th percentile over 90 days, suggesting that forward estimate revisions have been tepid despite the headline beat.

One institutional data point is worth flagging. Berkshire Hathaway's last disclosed position was 39 million shares, but that filing reflects the quarter ended June 30 and showed an 11 million share reduction from the prior period. That is a meaningful trim from a holder that had been a notable presence on the register. BlackRock added 1.2 million shares in the September quarter and remains the largest reported holder at 9.2% of shares. No 13D activist is on the register, and the 13G filings are all passive in character. Insider activity over the past 90 days has been net negative at roughly 103,000 shares, though the meaningful transactions in September were primarily option exercises and associated market sales by EVP Mary Ellen Adcock rather than discretionary open-market selling, which limits their signalling value.

With the next earnings date set for December 8, the focus shifts to whether the food volume trend stabilises or deteriorates further over the coming weeks. The analyst target gap between the most cautious voices (Citigroup at $57, Wells Fargo at $60) and the most bullish (Telsey at $75, Evercore at $70) is unusually wide, making the December print a genuine fork in the road for how the Street re-rates the stock into 2027.